Goldilocks Dilemma of Dose Titration in Heart Failure With Reduced Ejection Fraction: Too Little, Too Much, or Just Right?
作者信息
Allen Larry A, Fang James C
机构信息
From the Division of Cardiology, University of Colorado School of Medicine, Aurora (L.A.A.); and Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City (J.C.F.).
出版信息
Circ Heart Fail. 2017 Aug;10(8). doi: 10.1161/CIRCHEARTFAILURE.117.004406.
Abstract
摘要
相似文献
1
Goldilocks Dilemma of Dose Titration in Heart Failure With Reduced Ejection Fraction: Too Little, Too Much, or Just Right?射血分数降低的心力衰竭中剂量滴定的金发姑娘困境：太少、太多还是刚刚好？
Circ Heart Fail. 2017 Aug;10(8). doi: 10.1161/CIRCHEARTFAILURE.117.004406.
2
Nurse-Led Titration of Angiotensin-Converting Enzyme Inhibitors, β-Adrenergic Blocking Agents, and Angiotensin Receptor Blockers in Patients With Heart Failure With Reduced Ejection Fraction.护士主导的血管紧张素转换酶抑制剂、β-肾上腺素能受体阻滞剂和血管紧张素受体拮抗剂滴定治疗射血分数降低的心力衰竭患者。
JAMA Cardiol. 2016 Oct 1;1(7):842-843. doi: 10.1001/jamacardio.2016.2332.
3
Analysing registries in heart failure: The case of angiotensin receptor blockers in Asians with heart failure with reduced ejection fraction.
Int J Cardiol. 2018 Apr 15;257:224-225. doi: 10.1016/j.ijcard.2018.01.061.
4
Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.血管紧张素转换酶抑制剂或血管紧张素受体拮抗剂与射血分数保留的心力衰竭患者死亡率的相关性。
JAMA. 2012 Nov 28;308(20):2108-17. doi: 10.1001/jama.2012.14785.
5
Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.射血分数降低的心力衰竭住院患者中血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂的起始、持续使用或撤药与预后
J Am Heart Assoc. 2017 Feb 11;6(2):e004675. doi: 10.1161/JAHA.116.004675.
6
Angiotensin Receptor-Neprilysin Inhibition in Heart Failure With Reduced Ejection Fraction: A Paradigm for All?血管紧张素受体-中性肽链内切酶抑制在射血分数降低的心力衰竭中的应用：适用于所有人的范例？
JACC Heart Fail. 2016 Oct;4(10):823-825. doi: 10.1016/j.jchf.2016.07.013. Epub 2016 Sep 7.
7
Effects of angiotensin receptor blocker at discharge in patients with heart failure with reduced ejection fraction: Korean Acute Heart Failure (KorAHF) registry.射血分数降低的心力衰竭患者出院时应用血管紧张素受体阻滞剂的效果：韩国急性心力衰竭（KorAHF）注册研究。
Int J Cardiol. 2018 Apr 15;257:168-176. doi: 10.1016/j.ijcard.2017.12.002.
8
Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction.血管紧张素转换酶抑制剂、血管紧张素受体阻滞剂及其联合用药与射血分数降低的心力衰竭患者预后的比较关联
Int J Cardiol. 2015 Nov 15;199:415-23. doi: 10.1016/j.ijcard.2015.07.051. Epub 2015 Jul 21.
9
Foundations of Pharmacotherapy for Heart Failure With Reduced Ejection Fraction: Evidence Meets Practice, Part I.射血分数降低的心力衰竭药物治疗基础：证据与实践，第一部分
J Cardiovasc Nurs. 2016 Mar-Apr;31(2):101-13. doi: 10.1097/JCN.0000000000000284.
10
Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.心力衰竭和慢性肾脏病患者肾功能与血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂剂量的长期变化
Am Heart J. 2016 Aug;178:28-36. doi: 10.1016/j.ahj.2016.03.024. Epub 2016 Apr 30.
引用本文的文献
1
Trends in Frailty and Use of Evidence-Based Pharmacotherapy for Heart Failure in Australian Hospitalised Patients: An Observational Study.澳大利亚住院患者的衰弱趋势及心力衰竭循证药物治疗的应用：一项观察性研究
J Clin Med. 2021 Dec 10;10(24):5780. doi: 10.3390/jcm10245780.
本文引用的文献
1
Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂的剂量与心力衰竭的结局：一项荟萃分析
Circ Heart Fail. 2017 Aug;10(8). doi: 10.1161/CIRCHEARTFAILURE.117.003956.
2
Angiotensin-neprilysin inhibition versus enalapril in heart failure.血管紧张素-脑啡肽酶抑制剂与依那普利治疗心力衰竭的比较。
N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30.
3
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.2013年美国心脏病学会基金会/美国心脏协会心力衰竭管理指南：执行摘要：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2013 Oct 15;128(16):1810-52. doi: 10.1161/CIR.0b013e31829e8807. Epub 2013 Jun 5.
4
Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF.实施基于实践的绩效改进干预措施后，门诊心力衰竭患者的药物剂量：IMPROVE HF研究结果
Congest Heart Fail. 2012 Jan-Feb;18(1):9-17. doi: 10.1111/j.1751-7133.2011.00250.x. Epub 2011 Sep 19.
5
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.高剂量与低剂量氯沙坦对心力衰竭患者临床结局的影响（HEAAL研究）：一项随机双盲试验
Lancet. 2009 Nov 28;374(9704):1840-8. doi: 10.1016/S0140-6736(09)61913-9. Epub 2009 Nov 16.
6
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.血管紧张素转换酶抑制剂赖诺普利低剂量和高剂量对慢性心力衰竭发病率和死亡率的比较影响。ATLAS研究组
Circulation. 1999 Dec 7;100(23):2312-8. doi: 10.1161/01.cir.100.23.2312.
7
Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison. The NETWORK Investigators.依那普利治疗有症状慢性心力衰竭的临床结果；剂量比较。网络研究人员。
Eur Heart J. 1998 Mar;19(3):481-9. doi: 10.1053/euhj.1997.0839.
Zotero 插件